Skip to content

Abivax S.A.

ABVX· NasdaqCore metricsCIK 1956827

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.19%
Market cap
$7.09B
78.54M shares
Filings
106
—
—
—
-€336.10M
FY 2025N/M FY25 yoy
-€246.06M
FY 2025N/M FY25 yoy
-€161.27M
FY 2025derivedN/M FY25 yoy
-€4.83
FY 2025N/M FY25 yoy
€516.69M
FY 2025+258.3% FY25 yoy
$7.09B
—
—
—
—
—

Price

$90.2817.20%$18.76past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

€177.76MFY 2025
€177.76M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31€177,761,000reported
FY 20242024-12-31€146,532,000reported
FY 20232023-12-31€103,176,000reported
FY 20222022-12-31€48,295,000reported
FY 20212021-12-31€47,781,000reported

Pharmaceutical preparations

Abivax S.A. is the 43rd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Abivax S.A. · CIK 1956827 · Engraved from SEC EDGAR